S'abonner

Junctional epidermolysis bullosa in the Middle East: Clinical and genetic studies in a series of consanguineous families - 01/09/11

Doi : 10.1067/mjd.2002.119673 
Aoi Nakano, MD, PhDa, Gilles G. Lestringant, MDb, Tamar Paperna, PhDd, Reuven Bergman, MDe, Ruth Gershoni, MDd, Philippe Frossard, PhDc, Moien Kanaan, PhDf, Guerrino Meneguzzi, PhDg, Gabriele Richard, MDa, Ellen Pfendner, PhDa, Jouni Uitto, MD, PhDa, Leena Pulkkinen, PhDa, Eli Sprecher, MD, PhDa,e
Philadelphia, Pennsylvania; Al Ain, United Arab Emirates; Haifa, Israel; Bethlehem, West Bank; and Nice, France 
From the Department of Dermatology and Cutaneous Biology, Jefferson Medical College and Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphiaa; the Departments of Dermatologyb and Human Genetics,c Tawam Medical Center, Al Ain; Institute of Human Genetics,d and Department of Dermatology,e Rambam Medical Center, Haifa; Department of Life Sciences, Bethlehem University, Palestinian Authorityf; and Unite INSERM 385, Nice.g 

Abstract

Background: Junctional epidermolysis bullosa (JEB) is a group of inherited blistering diseases characterized by epidermal-dermal separation resulting from mutations that affect the function of critical components of the basement membrane zone. This group of autosomal recessive diseases is especially prevalent in regions where consanguinity is common, such as the Middle East. However, the clinical and genetic epidemiology of JEB in this region remains largely unexplored. Objective: The aim of the present study was to assess a series of consanguineous JEB families originating from the Middle East. Methods: We identified 7 families referred to us between 1998 and 1999 and originating from the United Arab Emirates, Saudi Arabia, Sudan, Yemen, and Israel. Histologic, immunofluorescence, and electron microscopy studies were performed to direct the subsequent molecular analysis. DNA obtained from all family members was amplified by means of polymerase chain reaction and analyzed by conformation-sensitive gel electrophoresis with subsequent direct sequencing. Results: In 6 families presenting with the clinical and histologic features distinctive for JEB, mutations in genes encoding 1 of the 3 subunit polypeptides of laminin-5 were identified. Two families each had mutations in LAMB3, 2 in LAMA3, and 2 in LAMC2. Out of 7 distinct mutations, 5 were novel and 2 were recurrent. No relationship was found between the presence of nonsense/frameshift mutations in laminin-5 genes and perinatal mortality, contradicting a major genotype-phenotype correlation previously reported in the European and US literature. Similarly, none of the recurrent LAMB3 hot spot mutations previously described in other populations was found in our series. Finally, in a family with the clinical diagnosis of generalized atrophic benign epidermolysis bullosa, a homozygous non-sense mutation in Col17A1 gene (encoding the BPAG2 antigen) was identified. Conclusion: The present report suggests (1) the existence of a unique spectrum of mutations in the Middle East populations and (2) the need for the implementation of a diagnostic strategy tailored to the genetic features of JEB in this region. (J Am Acad Dermatol 2002;46:510-6.)

Le texte complet de cet article est disponible en PDF.

Abbreviations : BM, CSGE, EM, GABEB, JEB, PCR-RFLP, PTC


Plan


 We acknowledge the support of DebRA of the United States for the DebRA Molecular Diagnostics Laboratory at the Department of Dermatology and Cutaneous Biology of Thomas Jefferson University. This study was supported by the US Public Health Service, National Institutes of Health grant POI-AR38923. Dr Sprecher is supported by the American Physicians Fellowship for Medicine in Israel.
 Conflict of interest: None.
 Reprint requests: Eli Sprecher, MD, PhD, Department of Dermatology, Rambam Medical Center, Haifa 31096, Israel.


© 2002  American Academy of Dermatology, Inc. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 46 - N° 4

P. 510-516 - avril 2002 Retour au numéro
Article précédent Article précédent
  • Use of isotretinoin (Accutane) in the United States: Rapid increase from 1992 through 2000
  • Diane K. Wysowski, Joslyn Swann, Amarilys Vega
| Article suivant Article suivant
  • Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily
  • Vera H. Price, Emory Menefee, Matilde Sanchez, Patrick Ruane, Keith D. Kaufman

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.